Test added stimulant medicine with rTMS for depression
Part of Mental health clinical trials.
This early study tests whether adding a stimulant medicine to repetitive TMS (a non-drug brain stimulation) can improve depression. It is aimed at people whose depression has not improved after at least two antidepressant tries.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old
- You have a current diagnosis of major depressive disorder
- Your depression has not responded to two prior antidepressant medicines taken at the right dose and time
- Your doctor feels it is safe for you to join
- You cannot have bipolar disorder, schizophrenia, or other past/known psychotic conditions
- You cannot have past stimulant misuse, current stimulant use, or current benzodiazepine use
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an alternating combination of brain stimulation and brain imaging to see if it helps people with depression that hasn’t improved with usual treatments. The goal is to find a safer, more effective approach for people whose depression has been very difficult to treat.
This study tests a new type of transcranial magnetic stimulation (TMS) for adults whose depression hasn't gotten better with medication. It compares the real treatment to a sham (inactive) version to see how well it works.
This trial tests whether using brain-related “biomarkers” from your scans to guide rTMS can improve depression that hasn’t responded to at least one antidepressant. It may help by targeting brain circuits linked to depression more precisely.
This study compares two early treatments for moderate to severe depression: a brain stimulation technique called repetitive transcranial magnetic stimulation (rTMS) and a common antidepressant medication (escitalopram). The goal is to see which approach works better for people who have not yet tried any antidepressant.
This trial tests a single day of ultra-accelerated brain stimulation (TMS) combined with a single dose of a study drug (NRX-101) to see if it can quickly reduce depression symptoms. It is an early-phase study, meaning the treatment is new and being tested for safety and effectiveness.
This study tests a new way of delivering brain stimulation called rTMS to treat depression that hasn't improved with standard treatments. The goal is to see if targeting specific brain areas helps reduce depression symptoms more effectively.
Hear when a new Major Depressive Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.